Indivior 提议新的公司结构以实现美国本土化

Reuters
2025.10.01 13:56
portai
我是 PortAI，我可以总结文章信息。

Indivior PLC has proposed a new corporate structure to change its domicile from the U.K. to the U.S. Shareholders will receive one share of Indivior Pharmaceuticals, Inc. (IPI) for each PLC share, with no additional equity raised. Indivior PLC will become a wholly owned subsidiary of IPI, which will be listed on NASDAQ under the symbol INDV. The scheme is expected to be effective by January 2026.

Oct 1 (Reuters) - Indivior PLC (2IVB.D) :

  • INDIVIOR PROPOSES NEW CORPORATE STRUCTURE TO ACHIEVE U.S. DOMICILIATION
  • INDIVIOR PLC - TO CHANGE DOMICILE FROM U.K. TO U.S.
  • INDIVIOR PLC - SHAREHOLDERS TO RECEIVE ONE IPI SHARE PER PLC SHARE
  • INDIVIOR PLC: NO ADDITIONAL EQUITY WILL BE RAISED BY IPI AS PART OF TRANSACTION
  • INDIVIOR PLC: INDIVIOR PLC WILL BECOME A DIRECT WHOLLY OWNED SUBSIDIARY OF IPI
  • INDIVIOR: WILL ESTABLISH NEW U.S. PARENT CO, INDIVIOR PHARMACEUTICALS, ABOVE EXISTING UK PARENT CO
  • INDIVIOR PLC - EXPECTS SCHEME EFFECTIVE JANUARY 2026, PLC SHARES EXCHANGED FOR IPI
  • INDIVIOR: IPI’S STOCK WILL BE LISTED ON NASDAQ AND WILL CONTINUE TO TRADE UNDER SYMBOL INDV Source text: Further company coverage: (2IVB.D)
来源：Reuters 本文版权归属原作者/机构所有。
当前内容仅代表作者观点，与本平台立场无关。内容仅供投资者参考，亦不构成任何投资建议。如对本平台提供的内容服务有任何疑问或建议，请联系我们。